<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="964">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03094325</url>
  </required_header>
  <id_info>
    <org_study_id>16-01729</org_study_id>
    <nct_id>NCT03094325</nct_id>
  </id_info>
  <brief_title>On-pump Intraoperative Echocardiography</brief_title>
  <acronym>OPIE</acronym>
  <official_title>On-pump Intraoperative Echocardiography (OPIE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is no current way to monitor the depth of surgical septal myectomy during the on-pump
      period in the OR. This is because the heart is empty of blood and TEE and epicardial imaging
      is impossible. A probe device used during in neurosurgery may make the surgical procedure
      more accurate and decrease complications of &quot;too little myectomy&quot; or &quot;too much myectomy&quot;. It
      may decrease the need for reoperation which is currently a risk of myectomy 1-2%.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study uses an ultrasound probe that is currently clinically used to assess
      pituitary anatomy, the Hitachi-Aloka high resolution pituitary transducer to measure left
      ventricular (LV) septal thickness during cardiopulmonary bypass in the performance of
      surgical septal myectomy. Septal thickness will be assessed and can be visualized during the
      procedure and if it is likely to improve the efficacy and safety of the procedure. The probe
      has FDA clearance for a variety of intra-operative surgical procedures but will be off-label
      for this cardiac surgical protocol.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 23, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
    <masking_description>Each of the 10 patients will have 4 measurements(OPIE &amp; TEE before cardiopulmonary bypass and OPIE &amp; TEE after cardiopulmonary bypass) in the septum using two techniques (TEE and OPIE Ultrasound Probe).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Difference between TEE measured septal thickness and the OPIE measured thickness before cardiopulmonary bypass</measure>
    <time_frame>1 Day</time_frame>
    <description>Center tendency parameters(mean, standard deviation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference between TEE measured septal thickness and the OPIE measured thickness after cardiopulmonary bypass</measure>
    <time_frame>1 Day</time_frame>
    <description>Center tendency parameters(mean, standard deviation)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Septal Myectomy</condition>
  <arm_group>
    <arm_group_label>Septal myectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pre Operative On-pump intraoperative echocardiography</intervention_name>
    <description>Center tendency parameters(mean, standard deviation) will be reported for each outcome.</description>
    <arm_group_label>Septal myectomy</arm_group_label>
    <other_name>OPIE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pre Operative Transesophageal echocardiography (TEE) imaging</intervention_name>
    <description>Center tendency parameters(mean, standard deviation) will be reported for each outcome.</description>
    <arm_group_label>Septal myectomy</arm_group_label>
    <other_name>TEE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Post Operative On-pump intraoperative echocardiography</intervention_name>
    <description>Center tendency parameters(mean, standard deviation) will be reported for each outcome.</description>
    <arm_group_label>Septal myectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Post Operative Transesophageal echocardiography (TEE) imaging</intervention_name>
    <description>Center tendency parameters(mean, standard deviation) will be reported for each outcome.</description>
    <arm_group_label>Septal myectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled to receive a septal myectomy.

        Exclusion Criteria:

          -  Less than 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Swistel</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Medical Center Institutional Review Boards</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 23, 2017</lastchanged_date>
  <firstreceived_date>March 23, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Septal Myectomy</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
